Italfarmaco Group is pleased to announce the marketing of GhemaXan, the first biosimilar of Enoxaparin Sodium developed and produced in Italy
Ghemaxan is indicated for the treatment of deep vein thrombosis and pulmonary embolism (except for PE which may require thrombolytic or surgical therapy), serious [...]